Latest news & insights
The Maddi Foundation selected as Boyds’ Charity of the Year
We are proud to announce that we have chosen to support The Maddi Foundation as our Charity of the Year for 2024.
Harriet Edwards explores the current landscape for genome editing technologies
An article authored by Harriet Edwards, Associate Director of Regulatory Affairs at Boyds, has been published in Cell & Gene Therapy Insights. In the viewpoint
How To De-Risk Your IND Webinar
On March 20, 2024 at 9 am PST, Boyds will host a webinar designed to provide attendees with a plan of action that can help to de-risk your Investigational New Drug (IND) application and expedite the path to gain study clearance.
Boyds is now a proud member of MassBio
As part of our continued growth plans in the US, Boyds is delighted to join MassBio as a proud member.
Boyds shortlisted for BioNow Business Support Award
Boyds is delighted to have been named as a finalist in the Business Support category of the BioNow Awards 2023.
Boyds joins Texas Healthcare and Bioscience Institute (THBI) as proud member
Boyds is delighted to have been named as a finalist in the Business Support category of the BioNow Awards 2023.
Boyds collaborates with BioPharma Connections
Boyds partners with BioPharma Connections in the company’s latest move to continue its growth in the U.S.
Double win for Boyds at TOPRA Awards 2023
The TOPRA Awards 2023 saw the Boyds team take home two awards, with our regulatory affairs team crowned winners of the Futures Award and our
